Evidence map›Paper›PMID 23211177›Full record

SynthesisThe British journal of general practice : the journal of the Royal College of General Practitioners2012

Telehealthcare for chronic obstructive pulmonary disease: Cochrane Review and meta-analysis.

Susannah McLean, Ulugbek Nurmatov, Joseph L Y Liu, Claudia Pagliari, Josip Car, Aziz Sheikh

2 registry-linked trialsAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in The British journal of general practice : the journal of the Royal College of General Practitioners, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 84 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02528370 nacompletednot on this map

Evaluation the Effectiveness of a Telemonitoring Program in a Cohort of COPD Patient With Frequent Readmissions

TypeinterventionalSponsorDr. Cristobal EstebanRan2010 to 2013Enrolled197ConditionsCOPDArmstelEPOC
NCT03741855 nacompletednot on this mapstarted 2018, after this paper: background citation

Evaluating the Cloud DX Platform as a Tool for Self-management and Asynchronous Remote-monitoring of Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorWomen's College HospitalRan2018 to 2019Enrolled122ConditionsChronic Obstructive Pulmonary DiseaseArmsCloud Dx Kit with self-monitoring, Cloud Dx Kit with remote-monitoring
3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. A Systematic Review and Meta-Analysis of Telemonitoring Interventions on Severe COPD Exacerbations.International journal of environmental research and public health · 2021
    Pooled it
  8. Pooled it
  9. Do telemedical interventions improve quality of life in patients with COPD? A systematic review.International journal of chronic obstructive pulmonary disease · 2016
    Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Digital health system for personalised COPD long-term management.BMC medical informatics and decision making · 2017
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susannah McLeanAllergy and Respiratory Research and eHealth Research Groups, Centre for Population Health Sciences, The University of Edinburgh, Edinburgh, UK. susannah.mclean@ed.ac.uk
Ulugbek Nurmatov
Joseph L Y Liu
Claudia Pagliari
Josip Car
Aziz Sheikh

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is common. Telehealthcare, involving personalised health care over a distance, is seen as having the potential to improve care for people with COPD.

aimTo systematically review the effectiveness of telehealthcare interventions in COPD to improve clinical and process outcomes. DESIGN AND

settingCochrane Systematic Review of randomised controlled trials.

methodsThe study involved searching the Cochrane Airways Group Register of Trials, which is derived from the Cochrane Central Register of Controlled Trials, MEDLINE, embase, and CINAHL, as well as searching registers of ongoing and unpublished trials. Randomised controlled trials comparing a telehealthcare intervention with a control intervention in people with a clinical diagnosis of COPD were identified. The main outcomes of interest were quality of life and risk of emergency department visit, hospitalisation, and death. Two authors independently selected trials for inclusion and extracted data. Study quality was assessed using the Cochrane Collaboration's risk of bias method. Meta-analysis was undertaken using fixed effect and/or random effects modelling.

resultsTen randomised controlled trials were included. Telehealthcare did not improve COPD quality of life: mean difference -6.57 (95% confidence interval [CI] = -13.62 to 0.48). However, there was a significant reduction in the odds ratios (ORs) of emergency department attendance (OR = 0.27; 95% CI = 0.11 to 0.66) and hospitalisation (OR = 0.46; 95% CI = 0.33 to 0.65). There was a non-significant change in the OR of death (OR = 1.05; 95% CI = 0.63 to 1.75).

conclusionIn COPD, telehealthcare interventions can significantly reduce the risk of emergency department attendance and hospitalisation, but has little effect on the risk of death.

Indexed as

TelemedicineAmbulatory CareEmergency Service, HospitalFemaleHospitalizationHumansMalePatient SatisfactionPulmonary Disease, Chronic ObstructiveQuality Assurance, Health CareQuality of LifeRandomized Controlled Trials as Topic

Identifiers

PMID23211177
PMCPMC3481514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.